By Matthew Mahady

Flash Findings: Cancer Facts: July 6, 2010

July 6th 2010

A collection of cancer statistics and facts

Physicans' Financial News: October 2007

June 30th 2010

Physicians' Financial News focuses on newsworthy and/or notable companies in the oncology/biotech sector. In this issue:1) Genentech: Continues to Grow Oncology Portfolio2) ImClone: Erbitux News Initially Raise ImClone Shares3) AstraZeneca: Prostate Drug Enters Phase II4) Kiadis Pharma: One Blood Cancer Treatment Clears Phase II Hurdles, Another May Hit Market By 20095) Big Pharma Stocks Show Signs of Life

FDA Grants Priority Review to Potential Liver Cancer Therapy

June 30th 2010

An oral therapy currently utilized in the treatment of advanced kidney cancer may be on the threshold of obtaining a major new indication.

Fast Facts: New Cancer Survival Data

June 29th 2010

New data recently published in the Journal of Clinical Oncology has provided a degree of hopeful news to oncologists and their patients, suggesting that progress is being made in the fight against cancer and that a number of trends are pointing toward continued gains.

Physicians' Financial News November 2007

June 29th 2010

Physicians' Financial News focuses on newsmaking and/or notable companies in the oncology/biotech sector. In this issue: 1) Pharmion: Oncology-Centered Focus Fuels Continued Pharmion Growth 2) Bristol-Myers Squibb: Treatment-Resistant Breast Cancer Targeted 3) Merger-Mania Poised to Envelop Biotech Sector? and more

Fast Facts: Skin Cancer and Melanoma

June 25th 2010

A collection of statistics and facts on skin cancer and melanoma

Physicians' Financial News: January 2008

June 25th 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue: 1) Bristol-Myers Squibb: BMS Boasts Bright Oncology Future 2) Infinity Pharmaceuticals and AstraZeneca: Prostate Cancer Partnership Begins to Bear Fruit 3) Genentech: Avastin Shown To Halt Brain Cancer Progress, and more

Physicians' Financial News: February 2008

June 23rd 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue: Millennium Pharmiceuticals, Inc.: Future Looking Bright After Record 2007 Eisai Co., Ltd.: Eisai Purchases MGI Pharma Amgen, Inc.: Denosumab Linked With Increased Bone Density in Breast Cancer Patients Genzyme Corporation: Thyrogen Captures New Thyroid Cancer� Related Indication

Fast Facts

June 23rd 2010

A collection of cancer statistics and facts.

Physicians' Financial News: March 2008

June 21st 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology biotechnology sector. In this issue: Novartis: Novartis Leverages Formidable Size and Pipeline to Maintain Strong Oncology Position Roche AG: Ventana Medical Systems Taken Over by Roche Schering Plough: Potential Melanoma Treatment Granted Priority Review Amgen: Studies Suggest Expanded Role for Vectibix in Colorectal Cancer OxiGene: Potential Platinum-Resistant Ovarian Cancer Treatment Hits a Key Phase II Target

Physicians' Financial News: April 2008

June 17th 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology biotechnology sector. In this issue: Sanofi-Aventis: Pushing Forward Pipeline, Products, and Profits OncoGenex Technologies: Prostate Cancer Product Candidate Hits Primary Phase II Endpoint GlaxoSmithKline (GSK) and Genmab: Potential Leukemia Treatment Shows Positive Response in Dual-Phase Trial Genentech: Avastin Approval Brightens Genentech's Outlook Adherex Technologies, Inc.: ADH-1 Attains Orphan Status Novacea: Potential Advanced Cancer Treatment Clears Key Phase I Hurdles

Physicians Financial News: June 15, 2010

June 15th 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology biotechnology sector. In this issue: Onyx Pharmaceuticals, Inc.: Flourishing on Strength of Single Agent With Multiple Applications Cephalon, Inc.: Chronic Lymphocytic Leukemia Treatment Approved: First New Option in Seven Years Non-Hodgkin's Lymphoma: New Challenges, New Hope Sunesis Pharmaceuticals, Inc.: Potential Ovarian Cancer Treatment Advancing Through Development Pipeline BioNumerik Pharmaceuticals, Inc. and ASKA Pharmaceutical: Enhanced Survival, Tolerability Observed in Joint Non-Small Cell Lung Cancer Trial

Physician's Financial News: June 10, 2010

June 10th 2010

ASCO Policy Change Creates Massive Avalanche of Pre-Meeting Data

June 9th 2010

When ASCO decision-makers decided to revise the manner in which they disseminate eagerly anticipated clinical research data, the news made headlines and reverberations that were felt throughout the worlds of oncology research, practice, finance, and investment.

The Academy: June 9, 2010

June 9th 2010

Academic research is fueling tremendous strides in oncology and biotechnology. The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

Physicians Financial News: June 8, 2010

June 8th 2010

Physician's Financial News: May 28, 2010

May 28th 2010

The Academy: May 26, 2010

May 26th 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

Physician's Financial News: May 26, 2010

May 26th 2010

Physicians' Financial News focuses on newsworthy and/or notable companies in the oncology/biotech sector.

Colon Cancer Oncogene Identified

May 24th 2010

Scientists at the Dana-Farber Cancer Institute, Boston, Massachusetts, have linked the CDK8 gene to colon cancer, a previously unsuspected association.